2024年12月19日 · Apri package insert / prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions and pharmacology.

2022年7月20日 · Apri® (desogestrel and ethinyl estradiol tablets USP) is indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. Oral contraceptives are highly effective.

2025年3月11日 · Apri is a birth control pill that people can use to help prevent pregnancy. It's a combined oral contraceptive (COC) that contains two hormones: desogestrel (a progestin) and ethinyl estradiol (an estrogen). Each pack has 21 active tablets and 7 inactive tablets.

Apri is a combination birth control pill containing female hormones that prevent ovulation (the release of an egg from an ovary). Apri also causes changes in your cervical mucus and uterine lining, making it harder for sperm to reach the uterus and harder for a …

Desogestrel and ethinyl estradiol combination is used to prevent pregnancy. It is a birth control pill that contains two types of hormones, desogestrel and ethinyl estradiol, and when taken properly, prevents pregnancy. It works by stopping a woman's egg from fully developing each month.

Increased risk of cervical cancer with OCP use, however HPV remains as main risk factor for this cancer; evidence suggests long-term use of OCPs, 5 or more years, may be associated with increased...

Apri (desogestrel and ethinyl estradiol) Tablets are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. Oral contraceptives are highly effective.

2021年12月15日 · Apri ® (desogestrel and ethinyl estradiol tablets USP) is indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception. Oral contraceptives are highly effective.

Detailed dosage guidelines and administration information for Apri (desogestrel and ethinyl estradiol). Includes dose adjustments, warnings and precautions.

(COC), vaginal ring, or transdermal patch): The woman should start APRI® preferably on the day after the last active tablet of her previous COC, but at the latest, on the day following the usual tablet-free or inactive tablet of her previous COC.